Abiomed’s Impella heart pumps show improved patient outcomes in studies
PROTECT 3 study showed improvement in clinical outcomes, revascularisation, and safety, compared to the PROTECT 2 Randomized Controlled…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
05 Nov 21
PROTECT 3 study showed improvement in clinical outcomes, revascularisation, and safety, compared to the PROTECT 2 Randomized Controlled…
02 Nov 21
The company stated that Trillium implantation take less than 15 minutes to complete
02 Nov 21
The patient was successfully treated who suffered from severe mitral valve regurgitation and heart failure
28 Oct 21
The new AI-enabled CVD prevention module has been developed by One Drop in collaboration with Bayer
22 Oct 21
Cardiogram has developed a cardiovascular health decision support application, which enables users to manage chronic health conditions and…
15 Oct 21
FEops HEARTguide is a procedure planning platform that facilitates pre-operative planning of left atrial appendage occlusion (LAAo) using…
07 Oct 21
The acquired business will enable Boston Scientific to expand its electrophysiology and structural heart product portfolios with the…
06 Oct 21
SuperSaturated Oxygen (SSO2) Therapy is the first and only FDA-approved treatment to significantly reduce myocardial damage in heart…
05 Oct 21
The study is designed to assess the safety and efficacy of Zoom 88 Large Distal Platform for aspiration…
01 Oct 21
SynCardia's TAH System features an implant, which is available in two sizes, including a 70cc version suitable for…